2,156 material Form 8-K filings that 1,847 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Sonoco said CEO R. Howard Coker will retire as director, president and chief executive officer effective December 31, 2026. The board named Ernest D. Haynes III, the company's president of Global Consumer Packaging, to succeed him as CEO and as a director on that date.
Coker's retirement is effective December 31, 2026; the board accepted his notice dated November 6, 2026.
Haynes, who joined Sonoco in 1997, has an annual base salary of $1,100,004 and a bonus target of 120% of salary.
CFO Paul Joachimczyk received a $1,500,000 restricted stock unit retention award that cliff vests on the second anniversary of the grant date.
Sonoco leadership, including Coker, Haynes and Joachimczyk, will present at an R.W. Baird conference webcast on November 10, 2026, starting 7:20 a.m. Central Time.
LKQ Corporation said Salvatore A. Abbate will become President and Chief Executive Officer and join the Board effective November 9, 2026, earlier than the previously announced December 15, 2026 start date. The change ends the interim Office of the CEO led by Chairman John Mendel and Audit Committee Chair Sue Gove, which had overseen operations since October 23, 2026.
Abbate's start date moved from December 15, 2026 to November 9, 2026
Abbate becomes principal executive officer for SEC rules on November 9, 2026
Interim Office of the CEO, Mendel and Gove, which oversaw operations since October 23, concludes
Chairman Mendel said the Board has full confidence in Abbate
SiriusXM announced that Board director Anjali Sud, current CEO of Tubi, will become Chief Executive Officer on January 1, 2027, succeeding Jennifer C. Witz, who steps down as CEO and board member at the end of December 31, 2026. Sud's employment agreement sets a $2,600,000 base salary, a target bonus of two times salary, and equity awards including a $10,000,000 sign-on grant, which shareholders can track in the filing.
Anjali Sud, 43, becomes CEO effective January 1, 2027, and will remain on the Board
Sud's employment agreement sets a $2,600,000 base salary and a target bonus equal to two times base salary
Sud's package includes a $10,000,000 sign-on RSU grant and $4,500,000 in time-based and $4,500,000 in performance-based RSUs
Witz will serve as an advisory consultant from January 1, 2027 through December 31, 2027 at $175,000 per month
Goodyear appointed Roger Wood, a current board member, as interim chief executive officer and president effective November 8, 2026, replacing Mark Stewart, who also resigned from the board. The company will search for a permanent successor while a board special committee continues a strategic review of its businesses and operations.
Wood's salary is $310,000 per month, plus a monthly restricted stock unit grant with a grant date value of $1,000,000 for up to five months or until a permanent successor is hired.
Stewart's separation is classified as a termination other than for Cause under the company's Executive Severance and Change in Control Plan.
Wood will step down as chair of the board's human capital and compensation committee and will not serve on the Human Capital and Compensation or Governance Committees while interim CEO.
Jerome Rouquet will become executive vice president and chief financial officer effective December 1, 2026, succeeding interim CFO Scott Deakin.
Azora Therapeutics appointed three new independent directors, Aida Habtezion, Paul Hastings and Thomas Soloway, effective November 3, 2026, and four directors resigned the same day, reducing the board to five members. Separately, 9,924,260 common shares were issued on conversion of Series A Preferred Stock, bringing common shares outstanding to 14,243,129 as of November 4, 2026.
Three directors appointed November 3, 2026: Aida Habtezion, M.D., Paul Hastings and Thomas Soloway; the board was reduced to five members
Four directors resigned effective November 3, 2026: J. Kermit Anderson, Cary J. Claiborne, Robertson H. Gilliland and Kevin Schuyler; Matthew Davidson was named board chair
9,924,260 common shares issued on automatic conversion of 9,924.260 Series A Preferred shares effective November 2, 2026; 3,006.341 preferred shares remain outstanding
Company has not finalized non-employee director compensation; no equity awards granted to the new directors
Vistance Networks CEO Chuck Treadway, who has led the company since October 2020, will step down as President, CEO and board member effective February 1, 2027, after resigning on November 4, 2026. The board has launched a search for a successor and retained an executive search firm, and Treadway's severance is contingent on signing a separation agreement with a general release.
Treadway resigned November 4, 2026 and leaves the CEO role and board on February 1, 2027.
Treadway's departure is treated as a resignation for good reason under his Severance Protection Agreement, with severance contingent on a separation agreement containing a general release.
The company says it returned $16.50 per share to shareholders through special cash distributions in 2026, including a $1.50 per share distribution payable November 6, 2026.
The company released third quarter 2026 results in a separate press release issued the same day, November 5, 2026.
Datavault AI's board appointed Brett Moyer as Chief Executive Officer and President, effective immediately, after Nathaniel Bradley was removed from that role on November 1, 2026. Board changes also name Kimberly Briskey Chair and Teresa Gallo Chief Operating Officer, a shake-up that bears on how the company is run and governed.
Brett Moyer, previously CFO and a director, named CEO and President effective November 6, 2026; Nathaniel Bradley removed as CEO on November 1, 2026
Stanley Mbugua, previously Chief Accounting Officer, named Chief Financial Officer; Teresa Gallo named Chief Operating Officer
Kimberly Briskey named Chair of the Board; Christopher R. Hardt named Chair of the Audit Committee
Company says it will report third-quarter 2026 results on a date to be announced
RPM International's Chairman and CEO Frank C. Sullivan announced on November 6, 2026 that he plans to retire within the next twelve to eighteen months. He will remain in his role until a successor is appointed and is expected to then stay on as Chair of the Board, as the company runs a succession planning process with its Board.
Frank C. Sullivan plans to retire in the next twelve to eighteen months, per the November 6, 2026 filing.
Sullivan has served nearly 25 years as Chairman and CEO and more than 40 years with the company.
He will remain CEO until his successor is appointed and is expected to stay on as Board Chair afterward.
GeoVax Labs said on November 5, 2026 that its Board terminated David A. Dodd as President and Chief Executive Officer, effective immediately, and treated the termination as for Cause under his 2018 Employment Agreement. Dodd remains a director and Chairman, and the company does not intend to pay the severance he would receive without Cause, but he may dispute the determination, which could lead to severance and option-vesting costs.
Termination of President and CEO David A. Dodd effective immediately, dated November 5, 2026; he remains a director and Chairman
Board cites Dodd's refusal to comply with Board-approved directives as the basis for Cause
Company does not intend to pay severance, including a cash payment of three times base salary and target bonus, or full option vesting; Dodd may dispute and claim these
Company states the termination is unrelated to its business operations, financial results, or previously filed financial statements
Power Solutions International's Chief Financial Officer, Xun (Ken) Li, notified the board on November 3, 2026, that he will resign, effective November 27, 2026, to pursue another professional opportunity. The company said the resignation was not the result of any disagreement with the company.
Xun (Ken) Li resigns as Chief Financial Officer, also serving as principal financial and principal accounting officer
Notice to the board given November 3, 2026; resignation effective November 27, 2026
Company states the departure was not due to any disagreement
Algorhythm Holdings' CEO and Chairman Andrew Thompson resigned effective immediately, with the board stating no disagreement over operations, policies or practices. Director Gregory D. Smith was appointed to both roles on November 2, 2026, under a CEO agreement with a base salary of $375,000 rising to $480,000 on performance conditions.
Andrew Thompson resigned as CEO and Chairman, accepted by the board on October 30, 2026.
Gregory D. Smith, age 67 and a board member since September 2026, became CEO and Chairman on November 2, 2026.
Smith's agreement provides a 2,119,542-share restricted stock award, with 1,059,771 shares vesting immediately and 1,059,771 vesting on the first anniversary of the effective date.
Severance equals two times base salary plus maximum annual bonus; the filing reports 40,848,979 common shares outstanding as of November 4, 2026.
Datavault AI's board removed Nathaniel Bradley as Chief Executive Officer and President and terminated his employment, effective immediately, on November 1, 2026. The action was approved by all directors except Mr. Bradley, who voted against it, and he continues to serve as a board member. The filing does not name a successor or an interim leader, leaving the company's top executive role open as of the filing date.
Removal effective November 1, 2026, with employment terminated immediately
Board action approved by all directors other than Mr. Bradley, who voted against it
Mr. Bradley remains a board member until the next annual meeting or earlier resignation or removal
Change Agents Corporation appointed Chief Strategy Officer Luisa Ingargiola as principal executive officer on November 4, 2026, until it names a new Chief Executive Officer, with no added compensation. The company also issued a $250,000 promissory note to Harllon Holdings LLC with a $75,000 original issue discount, requiring repayment of $325,000 on January 1, 2027, and agreed to issue 150,000 shares to consultants for services.
Luisa Ingargiola, Chief Strategy Officer since June 3, 2026, was appointed principal executive officer on November 4, 2026, and will receive no additional compensation for the role.
Promissory note issued November 4, 2026 to Harllon Holdings LLC: $250,000 principal, $75,000 original issue discount, $325,000 due January 1, 2027.
The note may be prepaid on December 1, 2026 for $312,000.
150,000 shares of common stock agreed to be issued to consultants for services, under the Section 4(a)(2) registration exemption.
Krispy Kreme's board approved an amendment to CEO Joshua Charlesworth's employment agreement on October 30, 2026. The change raises his annual cash target bonus from 100% to 150% of base salary, effective November 1, 2026, and increases his annual restricted stock unit grant from $1,000,000 to $2,500,000, starting with the 2027 grant. The filing does not state a financial reason for the change, but it raises the potential pay of the company's top executive.
Target annual cash bonus rises from 100% to 150% of base salary, effective November 1, 2026.
Annual restricted stock unit grant increases from $1,000,000 to $2,500,000, beginning with the 2027 annual grant.
Changes were approved by the Board of Directors on October 30, 2026 and disclosed in a filing dated November 5, 2026.
PNC's board appointed Alexander E. C. Overstrom, currently executive vice president and head of Retail Banking, as chief financial officer effective March 1, 2027. Robert Q. Reilly, the current CFO, will become executive vice chairman on the same date, serving as a senior executive advisor to Chairman and CEO William S. Demchak. The filing does not report financial results, so it contains no direct measure of business performance.
Alexander E. C. Overstrom, 42, joined PNC in 2014 and has led Retail Banking since July 2022.
Robert Q. Reilly has been CFO since 2013 and remains in the role until March 1, 2027.
Permanent successor for PNC Retail Banking will be named in the near future.
Blaize Holdings appointed Martin Costas as Chief Operations Officer and Chief Financial Officer, effective November 2, 2026, replacing CFO Harminder Sehmi, who is retiring and will assist with the transition through November 30, 2026. The filing discloses Costas's pay, including a $425,000 base salary and option grants, and the bonus he can earn tied to raising $10 million and $50 million in net financing proceeds, which links his incentive to capital raising.
Martin Costas appointed COO and CFO effective November 2, 2026; he reports to CEO Dinakar Munagala.
Harminder Sehmi retiring as CFO; transition expected to be completed by November 30, 2026.
Costas base salary is $425,000, with a target bonus of 50% of base salary tied to Qualified Financings: $10 million by December 31, 2026, and $50 million between January 1 and June 30, 2027.
Costas receives options on 4,787,837 time-vesting shares and 2,393,918 performance-vesting shares, the latter vesting if market capitalization is at least $500 million for 60 consecutive days.
Valion Bio, Inc. disclosed that Lisa Wolf, its President, Chief Operating Officer and Chief Financial Officer, has voluntarily resigned from all three roles, with the resignation effective December 11, 2026. The filing does not state a reason or name a successor, so shareholders will need to watch for a replacement announcement.
Lisa Wolf notified the Special Committee of the Board on October 31, 2026.
Her resignation covers the positions of President, Chief Operating Officer and Chief Financial Officer.
The resignation takes effect December 11, 2026, and had not yet taken effect as of the filing date.
Steven L. Bernstein retired as Chief Financial Officer, Treasurer and Secretary of Frequency Electronics, Inc. effective November 1, 2026, and will provide transition services under a consulting agreement with an initial term ending October 31, 2027. The filing sets out his consulting fee, post-retirement benefits and the conditions under which those benefits apply, which shareholders may want to note when assessing the company's finance leadership transition.
Retirement effective November 1, 2026; agreement signed October 31, 2026, effective November 1, 2026
Annual consulting fee of $282,505, paid monthly, plus pre-approved expense reimbursement
Initial consulting term ends October 31, 2027; equity awards continue to vest during the term
Annual lifetime benefit of $38,000 under his 2015 deferred compensation agreement if the term is completed or ended without Cause, subject to a release of claims
TransUnion's board appointed David Gilbert, currently Senior Vice President and CFO for International, as interim Chief Financial Officer effective January 1, 2027. The change follows CFO Todd Cello's previously announced resignation effective December 31, 2026, after which Cello will serve as a full-time advisor through March 1, 2027. The company says it continues to search for a permanent CFO.
David Gilbert, who joined TransUnion in 1991, becomes interim CFO effective January 1, 2027.
Gilbert receives a $15,000 monthly stipend for his interim service.
Separate retention awards include $150,000 in cash, paid 50% in June 2027 and 50% in December 2027, and restricted stock units with a $150,000 grant date value that vest on the first anniversary of the grant.
Todd Cello resigned as CFO on September 19, 2026, effective December 31, 2026.
BridgeBio Oncology Therapeutics said its Chief Medical and Development Officer, Yong Ben, gave notice of his resignation on October 30, 2026, effective January 8, 2027. The filing states the departure was not due to any disagreement with the company's operations, policies or practices, and it does not name a successor.
Yong Ben gave notice of resignation as Chief Medical and Development Officer on October 30, 2026.
Resignation takes effect January 8, 2027.
The company states the resignation was not due to any disagreement over operations, policies or practices.
Digital Turbine appointed Daniel Lentz as Chief Financial Officer effective November 2, 2026, replacing Joshua Kinsell, who was interim CFO and remains Chief Accounting Officer. Lentz's pay package includes a $450,000 base salary, a $100,000 signing bonus and performance- and time-based equity awards, which tie part of his compensation to future Adjusted EBITDA and relative shareholder return.
Daniel Lentz, 48, previously served as CFO of Commerce.com, Inc. from July 2023 until joining Digital Turbine.
Lentz's compensation includes a $450,000 annual base salary, a $100,000 signing bonus and a target annual bonus of up to 100% of base salary.
Lentz received long-term awards of $1,050,000 in performance stock units and $1,050,000 in time-based restricted stock units, granted November 30, 2026.
Joshua Kinsell stepped down as interim CFO effective November 2, 2026, and continues as Chief Accounting Officer.
Gibraltar Industries said Chief Financial Officer Joseph Lovechio will resign effective November 20, 2026, to pursue another opportunity, and that the filing states his departure was not due to any disagreement on operations, financial reporting, policies or practices. Treasurer Jeffrey Watorek will serve as Interim Chief Financial Officer while the company searches for a permanent successor. The change is a senior finance leadership transition, but the filing includes no financial results or guidance.
Joseph A. Lovechio resigns as Vice President and CFO, effective November 20, 2026
Jeffrey J. Watorek, Vice President and Treasurer, appointed Interim CFO, with $5,750 additional biweekly cash compensation
Lori Rizzo, Vice President and Corporate Controller, appointed principal accounting officer effective November 20, 2026
Company has commenced a search for its next Chief Financial Officer
Middleby said CEO Tim FitzGerald will step down as CEO and from the board effective March 31, 2027, and that Chief Commercial Officer Steve Spittle will become CEO on April 1, 2027. Spittle was named President effective November 5, 2026, and will join the board when he becomes CEO. The company said the succession follows its 2026 portfolio transformation and that it is also reporting third quarter 2026 results on the same day.
Timothy J. FitzGerald leaves the CEO role and the board effective March 31, 2027, and remains eligible for severance and pro-rated accelerated vesting of restricted stock units.
Steven P. Spittle became President effective November 5, 2026, and becomes CEO and a board member effective April 1, 2027.
Spittle's employment agreement, dated November 4, 2026, sets an annual base salary of $850,000 and eligibility for an annual bonus.
Tripadvisor said CEO Matt Goldberg will leave his roles as president, CEO and board member effective February 16, 2027, under a separation agreement signed November 4, 2026. CFO Michael Noonan will resign effective December 31, 2026 to pursue another opportunity, and Chief Strategy and Operations Officer Kristen Dalton will serve as interim CFO starting January 1, 2027. The filing says the departures are not the result of any disagreement with the company, and the board is working with an executive search firm to find successor leadership.
Goldberg's separation package includes $675,000 in base salary payments over 18 months and a $675,000 bonus-based payment, subject to a release and restrictive covenants.
Goldberg remains CEO through February 16, 2027, and Noonan remains CFO through December 31, 2026.
Kristen Dalton, Chief Strategy and Operations Officer since November 2025, becomes interim CFO on January 1, 2027.
Chair Jeremy Philips said the board is working with an executive search firm to identify candidates.
1stDibs reported third quarter 2026 net revenue of $23.1 million, up 5% year over year, and a net loss of $1.2 million, narrower than the $3.5 million loss a year earlier. The same day, the company said Chief Product and Marketing Officer Bradford Shellhammer will succeed David Rosenblatt as CEO on January 1, 2027, with Rosenblatt moving to Executive Chairperson.
Q3 2026 net revenue was $23.1 million, up 5% year over year; gross margin was 73.2%, compared with 74.3% in Q3 2025.
Q3 2026 Adjusted EBITDA was $1.0 million (4.5% margin), compared with $(0.2) million a year earlier; the company called it its fourth consecutive quarter of positive Adjusted EBITDA.
Q4 2026 guidance: net revenue $22.2 million to $23.4 million; Adjusted EBITDA margin 1% to 4%.
Shellhammer succeeds Rosenblatt as CEO on January 1, 2027; the board authorized a $5.0 million share repurchase on November 3, 2026.
Latigo Biotherapeutics reported a third-quarter 2026 net loss of $20.9 million, down from $24.8 million a year earlier, and cash of $401.2 million that the company expects will fund operations into 2029. The company also said Todd Smith became president and CEO effective November 3, 2026, replacing Nima Farzan, who also resigned from the board.
Q3 2026 net loss was $20.9 million, versus $24.8 million in Q3 2025; R&D expenses fell to $17.5 million from $22.1 million, while G&A rose to $5.4 million from $2.6 million.
Cash and cash equivalents were $401.2 million as of September 30, 2026, expected to fund current operating plans into 2029.
Todd Smith became CEO effective November 3, 2026, with a $775,000 base salary, a 70% target cash incentive, and an option award with a $20 million grant-date fair value.
Nima Farzan will remain an employee through January 1, 2027, receive his 2026 bonus at 100% of target, and then serve as a consultant through December 31, 2027.
Brady Corporation entered into a Share Exchange Agreement on November 4, 2026, in which William H. Brady III transferred all 1,769,314 of his Class B Common Stock shares to the company in exchange for an equal number of newly issued Class A Common Stock shares. As a result of the transaction, Elizabeth P. Bruno now holds 100% of the Class B Common Stock, representing all of the company's voting power and resulting in a change in control. Dr. Bruno also stepped down from independent board committees, and the company qualified as a controlled company under NYSE rules.
On November 4, 2026, William H. Brady III exchanged 1,769,314 shares of Class B Common Stock for 1,769,314 newly issued shares of Class A Common Stock.
Elizabeth P. Bruno acquired 100% control of the company's Class B Common Stock voting power, resulting in a change in control.
William H. Brady III agreed to a 24-month lock-up period on the newly issued Class A Common Stock.
Dr. Bruno stepped down from the Management Development and Compensation Committee and the Corporate Governance Committee.
Atmos Energy said Chairman Kim R. Cocklin will retire from the board and as Chairman at the 2027 Annual Meeting after reaching mandatory retirement age. The board approved combining the Chairman and Chief Executive Officer roles, so President and CEO J. Kevin Akers will become Chairman, subject to re-election as a director. Shareholders will see one executive holding both top roles, with an independent Lead Director continuing under the company's governance guidelines.
Kim R. Cocklin, Chairman since December 2020 and with the company since 2006, will not stand for re-election at the 2027 Annual Meeting.
J. Kevin Akers, President and CEO, will become Chairman of the Board at the 2027 Annual Meeting, subject to shareholder re-election.
Nancy K. Quinn, the current Lead Director, will continue in that role from the 2027 Annual Meeting, subject to her re-election.
The board approved the change on November 3, 2026; the filing says Cocklin's decision was not the result of any disagreement with the company.
HP's Board appointed Emma Walmsley, former CEO of GSK, as Chief Executive Officer effective January 4, 2027, succeeding interim CEO Bruce Broussard, who will become Board Chair on the same date and succeed Chip Bergh. The filing discloses her offer letter terms, including a $1,450,000 base salary, a $30,000,000 one-time inducement equity award and a $2,500,000 sign-on bonus, and the Board increases its authorized directorships from 12 to 13 to seat her. The filing contains no financial results, so the change is a leadership transition whose effect on performance is not stated.
Emma Walmsley, 57, served as GSK CEO from April 2017 until December 2025 and joins HP as CEO on January 4, 2027.
Bruce Broussard, interim CEO since February 2026, becomes Board Chair on January 4, 2027, succeeding Chip Bergh.
Offer letter sets a $1,450,000 annual base salary and a 200% target bonus, with a $30,000,000 one-time inducement equity award.
Walmsley receives a $2,500,000 sign-on bonus, subject to prorated repayment if she leaves voluntarily or is terminated for misconduct within 12 months.
MNTN reported third quarter 2026 revenue of $80.3 million, up 15% year over year, and net income of $7.7 million, up 19%. The board also named director Tony Weisman as President and CEO effective November 2, 2026, replacing Mark Douglas, who will leave the company on December 3, 2026. The company updated its full year 2026 guidance, which calls for fourth quarter revenue of $75 million to $78 million, below the third quarter level.
Q3 2026 revenue was $80.3 million, up 15% year over year; net income was $7.7 million, or $0.10 per diluted share, versus $6.4 million in Q3 2025
Full year 2026 revenue is expected at $311 million to $314 million, and Adjusted EBITDA at $66 million to $68 million
Q4 2026 revenue is expected at $75 million to $78 million and Adjusted EBITDA at $8 million to $10 million
CFO Patrick Pohlen cited unforeseen execution problems in the go-to-market organization and said the sales organization is being realigned
Ensysce Biosciences said director Will Chang intends to resign after the next annual meeting, and CEO Dr. Lynn Kirkpatrick will step down as CEO and take the title of Chief Operating Officer right after that meeting. President James Morrisson is set to become CEO at the same time, a change the company had previously reported, which gives shareholders a planned leadership transition.
Annual meeting scheduled for December 14, 2026; Kirkpatrick's title change and Chang's resignation take effect around it, and both would be delayed if the meeting is delayed.
James Morrisson, the company's President, will assume the title of Chief Executive Officer immediately after the annual meeting.
Kirkpatrick agreed to amend her September 14, 2021 employment offer letter so that taking the COO role will not trigger severance obligations.
Kirkpatrick has been CEO since January 2009 and also serves as CEO of EBIR, Inc., in which the company owns 79.2%.
Children's Place said its President and Interim Chief Executive Officer, Muhammad Asif Seemab, and Chief Strategy Officer, Muhammad Umair, resigned effective November 1, 2026, and that CFO John Szczepanski became acting President and principal executive officer under the bylaws. Board member Kim Roy and Executive Chairman Turki Saleh A. AlRajhi also stepped down, and the filing says none of the resignations involved disagreement over operations, policies, or practices. The filing does not describe a permanent successor or any change in financial results, so the effect on shareholders is unclear.
Seemab resigned as President and Interim CEO and Umair as Chief Strategy Officer, both effective November 1, 2026; both will remain on the Board
CFO John Szczepanski is acting President and principal executive officer effective November 1, 2026, with no new compensation arrangements
Kim Roy resigned from the Board effective immediately, notice dated October 30, 2026
Turki Saleh A. AlRajhi resigned as Executive Chairman on November 3, 2026, and remains Chairman of the Board
Siebert Financial Corp.'s Board of Directors appointed Richard S. Gebbia and David J. Gebbia as Co-Chief Executive Officers effective November 4, 2026. John J. Gebbia, the current CEO, steps away from the CEO position on that date and will continue as Chairman of the Board, so the leadership change is significant for shareholders.
Richard S. Gebbia and David J. Gebbia, both age 59, appointed Co-CEOs effective November 4, 2026
John J. Gebbia steps away from the CEO position on November 4, 2026 and remains Chairman of the Board
Richard S. Gebbia previously served as CEO of StockCross Financial Services, Inc. from 2007 to 2020; David J. Gebbia is President of Park Wilshire Companies, Inc. and Gebbia Holdings, LLC
The filing states the Gebbia sons are related to John J. Gebbia and that no arrangements exist under which they were selected as executive officers
Picard Medical's board appointed Richard Fang, Ph.D., as permanent, full-time Chief Executive Officer effective October 28, 2026; he had served as interim CEO since June 18, 2026 and remains Chairman. The filing also discloses related-person loans from a Fang-affiliated entity, and the company had not received the $1.0 million of external funding that would have kept the earliest of those loans from coming due, so they are now payable on terms yet to be determined.
Richard Fang, Ph.D., appointed permanent CEO effective October 28, 2026; salary remains $0.4 million with no new compensation arrangement
Fang-affiliated fund lent $0.5 million at 0% interest under five loans from July 29 to October 16, 2026; no principal repaid as of October 29, 2026
As of October 29, 2026, no external funding of at least $1.0 million received; earliest loans now due on payment terms to be determined
Separate $0.7 million loan from Fang Family Fund I, LLC at 6% interest, due February 28, 2027
Concentrix Corporation announced that Chinnu Susan Varghese will succeed Andre Valentine as Chief Financial Officer effective December 1, 2026. Mr. Valentine will remain in the role in the near term and stay through the second quarter of fiscal 2027 to support the transition.
Chinnu Susan Varghese joins Concentrix on November 9, 2026 and becomes CFO on December 1, 2026.
Andre Valentine stays on as CFO in the near term and is expected to remain with the company through the second quarter of fiscal 2027.
Ms. Varghese previously was Senior Vice President and Group Controller at Marelli and CFO, Global Growth Markets at Cognizant.
Accendra Health's Executive Vice President and Chief Operating Officer, Perry Bernocchi, will cease to be an executive officer under a transition agreement dated October 29, 2026, and serve as Strategic Advisor to the CEO until December 31, 2026, unless his employment ends earlier. He keeps his current base salary and remains eligible for his 2026 annual bonus at target and for applicable severance, which matters to shareholders as a senior operating leadership change.
Perry A. Bernocchi, EVP and Chief Operating Officer, ceases to be an executive officer under agreement dated October 29, 2026
Serves as Strategic Advisor to the Chief Executive Officer until December 31, 2026, unless employment ends earlier
Keeps current base salary and remains eligible for 2026 annual bonus at current target
Remains eligible for severance under Officer Severance Policy or change of control agreement, as applicable
ACM Research, Inc. announced that Yue Ma began work as Chief Operations Officer effective October 1, 2026, under an offer letter with a $375,000 base salary and a $100,000 target annual bonus. The filing also discloses equity grants and a sign-on bonus, which give the company a clear view of the cost of the appointment.
Base salary of $375,000 and target annual bonus of $100,000
Stock option for 100,000 Class A shares at $83.58 per share, vesting from October 1, 2027
Restricted stock units for 13,470 shares, vesting in four annual installments; one-time $50,000 sign-on bonus and relocation benefits up to $150,000
Pfizer's board unanimously elected Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026, after she served as interim CFO since August 16, 2026. The filing sets her base salary at $1,300,000 and her target annual cash incentive at $1,300,000, and it does not report any financial results or change to guidance.
Cecile Guegan appointed CFO and Executive Vice President, effective November 1, 2026; interim CFO since August 16, 2026
Annual base salary of $1,300,000
Annual target cash incentive of $1,300,000, equal to 100% of base salary
She will oversee all corporate finance functions, including audit, treasury, investor relations and tax
On November 3, 2026, First American Financial Corporation appointed Darryl D. Button to its Board of Directors, and he has not yet been named to any board committee. Button has been president and CEO of Pacific Mutual Holding Company since April 2022 and previously served as First American's chief financial officer from 2017 to 2021, so the appointment adds a director with prior company finance experience and current insurance leadership.
Darryl D. Button appointed to the board on November 3, 2026
No committee assignments yet, per the filing
Button has been president and CEO of Pacific Mutual Holding Company since April 2022
Previously served as First American's chief financial officer from 2017 to 2021
At its October 28, 2026 annual meeting, five director nominees did not receive a majority of votes cast and offered conditional resignations, which the board will accept or reject and announce within 90 days after certification. Shareholders also voted 956,752 against versus 422,593 for the say-on-pay proposal, and Executive Vice President Jamie Suarez is leaving his officer role after October 30, 2026, with employment ending November 22, 2026.
Five nominees did not win a majority: Andrew Alfano, Lockie Andrews, Nancy Benacci, Susan Lintonsmith and Michael Mansbach.
Say-on-pay vote: 956,752 against, 422,593 for and 76,907 abstain, with 592,063 broker non-votes.
The board will publicly announce its decision on the offered resignations within 90 days after the election results are certified.
Jamie Suarez's officer role ends at the end of October 30, 2026; his employment ends November 22, 2026, with severance subject to a release of claims.
Erie Indemnity CEO Timothy G. NeCastro retired on November 2, 2026, earlier than the previously announced December 31, 2026 date, citing personal reasons. Brian W. Bolash, the company's Executive Vice President, was appointed Interim President and CEO effective November 3, 2026, while the board's Nominating and Governance Committee continues its search for a permanent CEO.
Timothy G. NeCastro retired as President and CEO on November 2, 2026, accelerated from December 31, 2026 for personal reasons.
Brian W. Bolash, age 61, named Interim President and CEO effective November 3, 2026.
Bolash has been Executive Vice President since January 2022 and Secretary and General Counsel since October 2019.
No immediate compensation changes were reported; the board is still searching for a next President and CEO.
Beacon Financial Corporation entered into an employment agreement with Sean A. Gray, effective September 21, 2026, tied to his previously announced appointment as President and Chief Executive Officer of the Company and Beacon Bank & Trust. The filing sets his $1,000,000 base salary, a bonus target of 75% of base salary, and severance terms that increase if a termination follows a change in control.
Base salary of $1,000,000; annual bonus target of 75% of base salary
Annual equity awards with grant date fair value of 105% of base salary, plus a one-time restricted stock award of $275,000 vesting in three equal tranches
Severance on termination without cause or for good reason: two times base salary plus target bonus, rising to three times if within 24 months after a change in control
Ocean Capital Acquisition Corp's chief executive, chairman and director Kin (Stephen) Sze resigned effective October 30, 2026, and independent director Pok Yu (Augustine) Chow also resigned that day. On November 2, 2026, the board appointed Yiyan Li as CEO, chairman and director, and Stephen J. Posner as an independent director; Ms. Li will also act as principal financial officer until a chief financial officer is appointed.
Stephen Sze resigned as CEO, chairman and director on October 30, 2026; the filing says the resignation did not involve any disagreement with the company.
Augustine Chow resigned as independent director and from the Audit, Corporate Governance and Nominating, and Compensation committees on October 30, 2026.
Yiyan Li was appointed CEO, chairman and director on November 2, 2026, and serves as principal financial officer until a CFO is named.
Stephen J. Posner was appointed independent director on November 2, 2026, and joined the Audit, Corporate Governance and Nominating, and Compensation committees.
BGC Group announced that JP Aubin will step down from his Co-Chief Executive Officer role, his CEO of EMEA role, his Co-Global Head of Financial Services Brokerage role, and his executive officer position, effective at the close of business on December 31, 2026, when he becomes Vice Chairman. John J. Abularrage and Sean A. Windeatt will continue as Co-CEOs overseeing all regions and businesses, and the company says its strategy is unchanged. The filing contains no financial figures, so the change's effect on results is not quantified.
Effective date: close of business on December 31, 2026, when Aubin becomes Vice Chairman and reports to the Co-CEOs
Aubin steps down as Co-CEO, CEO of EMEA, Co-Global Head of Financial Services Brokerage, and executive officer
John J. Abularrage and Sean A. Windeatt continue as Co-CEOs overseeing all regions and businesses
Employment agreement amendment with BGC Brokers LP, Succursale de Genève dated October 28, 2026; press release issued November 3, 2026
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., who had served as interim CEO since May 4, 2026, as President and Chief Executive Officer effective immediately, and added her to the Board. The Board reduced its size from six to five seats and is searching for an additional independent director. Her base salary remains $500,000 with an anticipated bonus of 30% of base salary, and the Board plans to review her employment agreement; the filing contains no financial results.
Appointed CEO and President effective immediately, with appointment dated November 1, 2026
Served as interim CEO since May 4, 2026; previously Senior Vice President, Clinical Development from November 2023 to May 2025
Annual base salary remains $500,000; anticipated bonus is 30% of base salary
Board reduced from six to five seats; search underway for an independent director to fill the fifth seat
Three Axe Compute directors, including Chairman Charles L. Nuzum, resigned from the Board effective October 27, 2026, and the company said the resignations were not due to any disagreement over its operations, policies or practices. The Board now has four directors and three vacancies, and CEO Christopher Miglino was appointed Chair effective November 1, 2026, succeeding Mr. Nuzum. Shareholders face a smaller Board while it searches for new directors, and the departing directors are receiving consulting agreements tied to the divestiture of the Helomics business.
Charles L. Nuzum, Daniel E. Handley and Gregory S. St. Clair resigned from the Board and all committees effective October 27, 2026.
The Board now has four directors, three of whom are Nasdaq-independent, and three vacancies.
Christopher Miglino, CEO and a director, was appointed Chair effective November 1, 2026, with no additional compensation.
Handley will receive a $120,000 cash payment; Nuzum and St. Clair will each receive restricted stock valued at $150,000 that vests six months after their consulting agreement's effective date.
Telos Corporation's board appointed Mark D. Griffin, an insider who joined the company in 1984, as President and Chief Executive Officer effective November 2, 2026, succeeding John B. Wood, who became Executive Chairman. The filing says Wood's transition was not the result of any disagreement with the company, and it sets out Griffin's $440,000 base salary and severance terms. The company will report third quarter 2026 results on November 9, 2026, the first earnings release under the new CEO.
Mark D. Griffin, age 66, named President and CEO effective November 2, 2026; previously Executive Vice President of Security Solutions since 2021
John B. Wood, CEO since 1994, becomes Executive Chairman and remains Chairman of the Board; his salary and benefits are unchanged
Griffin's employment agreement sets an annual base salary of $440,000 and 24 months of severance if terminated without cause or due to disability
Telos will report third quarter 2026 financial results on Monday, November 9, 2026
Three Anavex directors, including Chair Jiong Ma, resigned effective October 28, 2026, each citing views on strategy not aligned with the Board and management. The Board then reconstituted its audit, compensation and nominating committees on November 1, 2026, with new chairs and members.
Jiong Ma (Chair), Gautam Patel and Adrian Senderowicz resigned from the Board effective October 28, 2026
Ma and Patel cited strategic views not aligned with the Board and management; Patel and Senderowicz cited strategy to execute the business plan
Dr. Claus van der Velden chairs the Audit Committee; Dr. Peter Donhauser chairs the Compensation Committee; Dr. Axel Paeger chairs Nominating & Corporate Governance
Resignation letters are filed as Exhibits 17.1, 17.2 and 17.3
Keysight appointed Jason Kary, its current Senior Vice President and President of the Electronic Industrial Solutions Group, as Senior Vice President and Chief Financial Officer, effective December 18, 2026. He succeeds Neil Dougherty, who notified the company on October 29, 2026 that he will step down for personal reasons and will provide transition services through the end of fiscal 2027. The company said it is not updating its outlook for the fourth fiscal quarter of 2026 and will report those results on November 19.
Jason Kary becomes CFO effective December 18, 2026, succeeding Neil Dougherty, who was CFO for 13 years.
Dougherty notified the company on October 29, 2026 and will provide transition and other services through the end of fiscal 2027.
Keysight is not updating its previously provided fourth-quarter fiscal 2026 outlook; results are due November 19.
Compensation terms for Dougherty and Kary have not been determined and will be disclosed in a later filing amendment.
Lennox International said segment president Joseph Nassab will retire from his role on December 31, 2026, and stay on as a Strategic Advisor through February 28, 2028. Geoff Dethlefsen, currently Vice President and General Manager of Lennox Commercial HVAC, will succeed him as Executive Vice President and President, Building Climate Solutions, effective January 1, 2027. The filing describes a planned leadership handover with no financial results or guidance included.
Joseph F. Nassab retires from his role on December 31, 2026, and becomes a Strategic Advisor, with a transition agreement effective January 1, 2027, running through February 28, 2028.
Nassab will receive an annual salary of $180,000 as an advisor and continue vesting in outstanding equity awards per their terms.
Geoff Dethlefsen succeeds Nassab as Executive Vice President and President, Building Climate Solutions, effective January 1, 2027.
The press release says Dethlefsen joined Lennox in 2024 and that Nassab joined the company in 2010.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.